Association of SET domain and myotubularin-related proteins modulates growth control

Nature Genetics

Volumn 18, Issue 4, 1998, Pages 331-337

  Cui, Xiangmin ^a   De Vivo, Immaculata ^a   Slany, Robert ^a   Miyamoto, Alison ^a   Firestein, Ron ^a   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MYOTUBULARIN; MYOTUBULARIN RELATED PROTEIN; PHOSPHATASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CENTRONUCLEAR MYOPATHY; DROSOPHILA; GENE EXPRESSION REGULATION; GENE MUTATION; GROWTH REGULATION; MARKER GENE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; YEAST;

ANIMALIA;

EID: 0031945475     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0498-331     Document Type: Article

References (42)

1. Stassen, M.J. et al. The Drosophila trithorax proteins contain a novel variant of the nuclear receptor type DMA binding domain and an ancient conserved motif found in other chromosomal proteins. Mech. Dev. 52, 209-223 (1995).
2. Tschiersch, B. et al. The protein encoded by the Drosophila position-effect variegation suppressor gene Su(var)3-9 combines domains of antagonistic regulators of homeotic gene complexes. EMBO J. 13,3822-3831 (1994).
3. Tkachuk, D.C., Kohler, S. & Cleary, M.L Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71, 691-700(1992).
4. Gu, Y. et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALU gene, related to Drosophila trithorax, to the AF~4 gene. Cell 71, 701-708(1992).
5. Djabali, M.L. et al. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukemia. Nature Genet. 2,113-118 (1992).
6. Jones, R.S. & Gelbart, W.M. The Drosophila polycomb-group gene Enhancer of zeste contains a region with sequence similarity to trithorax. Mot. Cell. Biot. 13, 6357-6366(1993).
7. Kennison, J.A. & Tamkun, J.W. Dosage-dependent modifiers of polycomb and antennapedia mutations in Drosophila. Proc. WatJ. Acad. Sei. USA 85, 8135-8140 (1988).
8. Kennison, J.A. The Polycomb and trithorax group proteins of Drosophila: transregulators of homeotic gene function. Anna. Rev. Genet. 29,289-303 (1995).
9. Paro, R. Imprinting a determined state into the chromatin of Drosophila. Trends Genet. 6,416-421(1990).
10. Pirotta, V. PcG complexes and chromatin silencing. Curr. Opin. Genet. Dev. 7, 249-258 (1997).
11. Tripoulas, N., LaJeunesse, D., Gildea, J. S Shearn, A. The Drosophila ash1 gene product, which is localized at specific sites on polytene chromosomes, contains a SET domain and a PHD finger. Genetics 143, 913-928 (1996).
12. Chinwalla, V., Jane, E.P. & Harte, P.J. The Drosophila trithorax protein binds to specific chromosomal sites and is co-localized with Polycomb at many sites. EMBOJ. 14, 2056-2065 (1995).
13. Rastelli, L, Chan, C.S. & Pirotta, V. Related chromosome binding sites for zeste, suppressors of zeste and Polycomb group proteins in Drosophila and their dependence on Enhancer of zeste function, EMBO J. 12,1513-1522 (1993).
14. Yu, B.D. et al. Altered Hox expression and segmental identity in MLL-mulant mice. Nature 378, 505-508 (1995).
15. Nislow, C, Ray. E. & Pillus, L SET1, a yeast member of the Trithorax family, functions in transcriptional silencing and diverse cellular processes. Mol. Biol. Cell 8,2421-2436(1997).
16. Laible, G. et al. Mammalian homologues of the Polycomb-group gene Enhancer of Zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres. EMBOJ. IS, 3219-3232 (1997).
17. Laporte, J. et al. A gene mutated in X-linked myotubutar myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nature Genet. 13,175-182(1996).
18. Fischer, E.H., Charbonneau, H. & Tonks, N.K. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253, 401-406(1991).
19. Butler, L.H. et al. The HRX proto-oncogene product is widely expressed inhuman tissues and localises to nuclear structures. Blood, 89, 3361-3370 (1997).
20. Rohan, P.J. et al. PAC-1: A mitogen-induced nuclear protein tyrosine phosphatase. Sc/ence 259, 1763-1766(1993).
21. Sun, H. et al. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493(1993).
22. Ward, Y. et al. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature 367, 651-654 (1994).
23. Streuli, M. Protein tyrosine phosphatases in signaling. Curr. Opin. Cell Biol. 8,182-188(1996).
24. Rost, B. & Sander, C. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19, 55-72 (1994).
25. Denu, J.M. et al. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc. WatJ. Acad. Sei. USA 93. 2493-2498 (1996).
26. Barford, D., Flint, A.J. & Tonks, N.K. Crystal structure of human protein tyrosine phosphatase 1B. Science 263.1397-1404 (1994).
27. Yuvaniyama, J. et al. Crystal structure of the dual specificity protein phosphatase VHR. Science 272.1328-1331 (1996).
28. Guan, K.L. & Dixon, J.E. Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J. Biol. Chem. 266. 17026-17030(1991).
29. Wishart, M.J. état. A single mutation converts a novel phosphotyrosine binding domain into a dual-specificity phosphatase. J. Biol. Chem. 270, 26782-26785 (1995).
30. Denu, J.M. et al. Form and function in protein dephosphorylation. Cell 87, 361-364(1996).
31. Galaktionov, K. et al. CDC25 phosphatases as potential human oncogenes. Science 269, 1575-1577(1995).
32. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275,1943-1947 (1997).
33. Steck, P.A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet.15, 356-362(1997).
34. Liaw, D. et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet. 16, 64-67 (1997).
35. Garton, A.J., Flint, A.J. & Tonks, N.K. Identification of p130(cas) as a substrate for the cytosolic protein tyrosine phosphatase PTP-PEST. Mol. Cell. Biol. 16, 6408-6418(1996).
36. Flint, A.J., Tiganis, T., Barford, D. & Tonks, N.K. Development of 'substrate trapping' mutants to identify physiological substrates of protein tyrosine phosphatases. Proc. Natl.'Acad. Sei. USA 94,1680-1685 (1997).
37. Waring, P.M. & Cleary, M.L. Disruption of a homolog of trithorax by 11q23 translocations: Leukemogenic and transcriptional implications. Curr. Top. Microbiol. Immunol. 220,1-23 (1997).
38. Lavau, C, Szilvassy, S., Slany, R. & Cleary, M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRXENL. CMBOJ. 16, 4226-4237 (1997).
39. Slany, R., Lavau, C. & Cleary, M.L. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DMA binding motifs of HRX. Mol. Cell. Biol. 18. 122-129 (1998).
40. 124 in the dual specificity phosphatase VHR. J. Biol. Chem. 269, 28284-28090 (1994).
41. Baskaran, R., Dahmas, M.E. S Wang. J.Y. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. WatJ. Acad. Sei. USA 90,11167-11171(1993).
42. Streuli, M. et al. A family of receptor-linked protein tyrosine phosphatases in humans and Drosophi/a. Proc. Nail. Acad. Sei. USA 86,8698-8702 (1989).